[Hormonal contraception and the growth of neoplasm].
D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced / Q000235:genetics; D002715:Chlormadinone Acetate / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004285:Dogs; D004717:Endometrium; D005260:Female; D005500:Follow-Up Studies; D005833:Genital Neoplasms, Female / Q000139:chemically induced*; D000882:Haplorhini; D006801:Humans; D008325:Mammary Neoplasms, Experimental; D008656:Mestranol / Q000009:adverse effects; D009369:Neoplasms / Q000517:prevention & control; D009374:Neoplasms, Experimental; D009641:Norethynodrel / Q000009:adverse effects; D011230:Precancerous Conditions / Q000139:chemically induced; D011247:Pregnancy; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced; D014625:Vaginal Neoplasms / Q000139:chemically induced; D014626:Vaginal Smears
D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D009641:Norethynodrel; D008656:Mestranol
Hormonale Kontrazeption und Geschwulstwachstum.